February 24, 2020
Cell and Gene Therapy Companies Raised $6.4 Billion in 2019 for Rare Disease
Read More
February 24, 2020
Galderma Reports Positive Results from Mid-Stage Study of Therapy for Rare Skin Condition
Read More
February 21, 2020
Targeting a Common Link in Otherwise Different Rare Diseases
Read More
February 21, 2020
FDA Grants BioMarin Priority Review for Hemophilia A Gene Therapy
Read More
February 21, 2020
The Lost Art of Letter Writing
Read More
February 20, 2020
Spruce Biosciences Raises $88 Million to Advance Rare Endocrine Disease Pipeline
Read More
February 20, 2020
EC Approves Pfizer’s Vyndaqel for ATTR-CM
Read More
February 19, 2020
CANbridge Raises $98 Million to Advance Rare Disease Pipeline
Read More
February 19, 2020
Univercells Scores Up to $54 Million Investment from KKR
Read More
February 19, 2020
Avrobio, Catalyst, Complete Offerings
Read More
February 18, 2020
Gene Therapy Biotech Adverum Raises $150 Million in Public Offering
Read More
February 12, 2020
Ligand Buys Icagen’s Core Assets, Partnered Programs with Roche and CF Foundation
Read More
Load More
X